NO20040815L - Anvendelse av antroquinoner i behandling av nyresykdom. - Google Patents

Anvendelse av antroquinoner i behandling av nyresykdom.

Info

Publication number
NO20040815L
NO20040815L NO20040815A NO20040815A NO20040815L NO 20040815 L NO20040815 L NO 20040815L NO 20040815 A NO20040815 A NO 20040815A NO 20040815 A NO20040815 A NO 20040815A NO 20040815 L NO20040815 L NO 20040815L
Authority
NO
Norway
Prior art keywords
anthroquinones
treatment
kidney disease
kidney
disease
Prior art date
Application number
NO20040815A
Other languages
English (en)
Inventor
Robin Mark Bannister
Alan Rothaul
Nicola Cooper
Original Assignee
Arakis Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB0120788A external-priority patent/GB0120788D0/en
Priority claimed from GB0120783A external-priority patent/GB0120783D0/en
Application filed by Arakis Ltd filed Critical Arakis Ltd
Publication of NO20040815L publication Critical patent/NO20040815L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02E—REDUCTION OF GREENHOUSE GAS [GHG] EMISSIONS, RELATED TO ENERGY GENERATION, TRANSMISSION OR DISTRIBUTION
    • Y02E60/00—Enabling technologies; Technologies with a potential or indirect contribution to GHG emissions mitigation
    • Y02E60/30—Hydrogen technology
    • Y02E60/36—Hydrogen production from non-carbon containing sources, e.g. by water electrolysis

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Urology & Nephrology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NO20040815A 2001-08-25 2004-02-24 Anvendelse av antroquinoner i behandling av nyresykdom. NO20040815L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB0120788A GB0120788D0 (en) 2001-08-25 2001-08-25 The treatment of kidney disease
GB0120783A GB0120783D0 (en) 2001-08-25 2001-08-25 The treatment of lupus nephritis
PCT/GB2002/003921 WO2003017997A1 (en) 2001-08-25 2002-08-27 The use of anthroquinones in the treatment of kidney disease

Publications (1)

Publication Number Publication Date
NO20040815L true NO20040815L (no) 2004-02-24

Family

ID=26246480

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20040815A NO20040815L (no) 2001-08-25 2004-02-24 Anvendelse av antroquinoner i behandling av nyresykdom.

Country Status (13)

Country Link
US (1) US20040248864A1 (no)
EP (1) EP1418901A1 (no)
JP (1) JP2005504054A (no)
CN (1) CN1547468A (no)
BR (1) BR0211948A (no)
CA (1) CA2458129A1 (no)
HU (1) HUP0401640A2 (no)
IL (1) IL160310A0 (no)
MX (1) MXPA04001659A (no)
NO (1) NO20040815L (no)
NZ (1) NZ530956A (no)
PL (1) PL369123A1 (no)
WO (1) WO2003017997A1 (no)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1748675A (zh) * 2005-07-11 2006-03-22 丛晓东 大黄酸类化合物的复合物及制备方法与治疗糖尿病的应用
TWI473610B (zh) * 2008-10-28 2015-02-21 Twi Biotechnology Inc 包含雙醋瑞因（ｄｉａｃｅｒｅｉｎ）之醫藥組合物
CN101537002B (zh) * 2009-04-24 2012-02-29 安士制药（中山）有限公司 具有优良溶出性能的双醋瑞因组合物及其制备和用途
CN104042594A (zh) * 2013-03-15 2014-09-17 复旦大学 蒽醌类化合物在制备抗补体药物中的用途

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1086289C (zh) * 1997-09-30 2002-06-19 中国人民解放军肾脏病研究所 大黄酸或大黄酸盐在制备治疗糖尿病肾病药中的用途
US6197818B1 (en) * 1998-09-01 2001-03-06 Nanjing General Hospital Of Nanjing Command, Pla Drug for treating diabetic nephrosis
US7087608B2 (en) * 2000-03-03 2006-08-08 Robert Charles Atkins Use of PDGF receptor tyrosine kinase inhibitors for the treatment of diabetic nephropathy

Also Published As

Publication number Publication date
BR0211948A (pt) 2004-09-14
US20040248864A1 (en) 2004-12-09
WO2003017997A1 (en) 2003-03-06
EP1418901A1 (en) 2004-05-19
HUP0401640A2 (hu) 2004-12-28
JP2005504054A (ja) 2005-02-10
CA2458129A1 (en) 2003-03-06
CN1547468A (zh) 2004-11-17
PL369123A1 (en) 2005-04-18
MXPA04001659A (es) 2004-05-31
NZ530956A (en) 2005-08-26
IL160310A0 (en) 2004-07-25

Similar Documents

Publication Publication Date Title
NO20041588L (no) Anvendelse av flibanserin ved behandling av seksuelle forstyrrelser
AP2004003002A0 (en) azabicyclic-substituted fused-heteroaryl compoundsfor the treatment of disease.
EE05507B1 (et) Rosuvastatiini ZD4522) kasutamine heterosgootseperekondliku hperkolesteroleemia raviks
NO20041882L (no) Fremgangsmater for behandling av okulare neovaskulaere sykdommer.
DE60237823D1 (de) Medizinisches behandlungsinstrument
DE60225431D1 (de) Dialysekatheter
DK1697378T3 (da) Indoler, 1H-indazoler, 1,2-benzisoxazoler og 1,2-benzisothiazoler og fremstilling og anvendelser deraf
DK1392287T3 (da) Anvendelse af substituerede azetidinonderivater i behandlingen af Alzheimers sygdom
MXPA03002813A (es) Compuestos utiles en el tratamiento de enfermedades inflamatorias.
IS7815A (is) 3-Fenýl setið pýridóindólón, framleiðsla og meðferðarleg notkun þess.
IS6918A (is) Meðferð erfiðra æxla með notkun epóþílon afleiða
IS6966A (is) Cýanó-tengd díhýdrópýrimídín efnasambönd og notkun þeirra við meðhöndlun sjúkdóma
IS6967A (is) Ný cýanó-tengd díhýdrópýrimídín efnasambönd og notkun þeirra við meðhöndlun sjúkdóma
DE60223576D1 (de) Hautbehandlungszusammensetzung
IS7163A (is) Aðferðir til meðhöndlunar á lungnasjúkdómi
ZA200307475B (en) Carbamate compounds for use in the treatment of pain.
DK1670482T4 (da) Anvendelse af ciclesonid til behandlingen af respiratoriske sygdomme
DE60220220D1 (de) Blutbehandlungssystem
BR0112264B1 (pt) dispositivo de tratamento de sangue.
DE60222664D1 (de) Hautbehandlungsmittel
NO20054034D0 (no) Fremgangsmate for behandling av hypotyroidisme.
NO20040815L (no) Anvendelse av antroquinoner i behandling av nyresykdom.
DK1496918T3 (da) Anvendelse af natriummetaarsenit til behandling af tumorer
DK1461042T3 (da) Anvendelse af desoxypeganin til behandling af klinisk depression
MXPA03003032A (es) Terapia de combinacion para el tratamiento de una enfermedad sensible a los estrogenos.

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application